- Home
- GERN vs AZZ Comparison
GERN vs AZZ Comparison
Compare GERN & AZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- AZZ
- Stock Information
- Founded
- GERN 1990
- AZZ 1956
- Country
- GERN United States
- AZZ United States
- Employees
- GERN N/A
- AZZ N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- AZZ Industrial Specialties
- Sector
- GERN Health Care
- AZZ Industrials
- Exchange
- GERN Nasdaq
- AZZ Nasdaq
- Market Cap
- GERN 2.5B
- AZZ 2.8B
- IPO Year
- GERN 1996
- AZZ N/A
- Fundamental
- Price
- GERN $3.34
- AZZ $82.72
- Analyst Decision
- GERN Strong Buy
- AZZ Buy
- Analyst Count
- GERN 10
- AZZ 6
- Target Price
- GERN $7.05
- AZZ $96.80
- AVG Volume (30 Days)
- GERN 8.0M
- AZZ 186.6K
- Earning Date
- GERN 11-07-2024
- AZZ 01-08-2025
- Dividend Yield
- GERN N/A
- AZZ 0.83%
- EPS Growth
- GERN N/A
- AZZ 17.78
- EPS
- GERN N/A
- AZZ 1.08
- Revenue
- GERN $29,480,000.00
- AZZ $1,570,389,000.00
- Revenue This Year
- GERN $32,021.10
- AZZ $4.90
- Revenue Next Year
- GERN $298.14
- AZZ $5.46
- P/E Ratio
- GERN N/A
- AZZ $76.25
- Revenue Growth
- GERN 9199.68
- AZZ 4.75
- 52 Week Low
- GERN $1.64
- AZZ $55.78
- 52 Week High
- GERN $5.34
- AZZ $97.98
- Technical
- Relative Strength Index (RSI)
- GERN 25.88
- AZZ 37.28
- Support Level
- GERN $3.75
- AZZ $92.26
- Resistance Level
- GERN $4.00
- AZZ $97.12
- Average True Range (ATR)
- GERN 0.17
- AZZ 3.23
- MACD
- GERN -0.06
- AZZ -1.90
- Stochastic Oscillator
- GERN 7.41
- AZZ 14.29
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. In its Metal Coatings segment, the company offers metal finishing services to protect against corrosion, such as hot dip galvanizing, spin galvanizing, powder coating, anodizing, and plating. The Precoat Metals Segment offers aesthetic and corrosion-resistant coatings for steel and aluminum coils.